Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Drug pedigree rule on hold

Executive Summary

A federal court ruling blocks FDA from enforcing the pharmaceutical pedigree requirements set forth in the Prescription Drug Marketing Act. The bench ruling was issued Dec. 4 by Judge Joanna Seybert of the U.S. District Court for the Eastern District of New York. Secondary distributors RxUSA Wholesale, Alden Surgical, Atlantic Biologics, Bell Medical Services, Truxton, Hygen Pharmaceuticals and Stat Pharmaceuticals filed for the preliminary injunction Sept. 20, seeking to prevent FDA from implementing the final pedigree rule. Magistrate Judge Kathleen Tomlinson recommended Nov. 30 that the district court grant the preliminary injunction, saying that plaintiffs have demonstrated the provision of the PDMA exempting authorized distributors from pedigree requirements may be ruled unconstitutional. FDA announced this summer that it would allow to expire a more than 10-year long stay that has delayed implementation of the PDMA pedigree requirements (1"The Pink Sheet" July, 10, 2006, p. 15)...

You may also be interested in...



FDA Begins Review Of E-Pedigree Options Just As California Delays Its Plan

With testimony that fewer than one in seven pharmaceutical manufacturers could be ready for California's planned implementation of electronic pedigree rules on Jan. 1, 2009, the State Board of Pharmacy decided to delay implementation for another two years

Prenatal Vitamin D Benefit In Preventing Childhood Asthma Fades By Age 6

University of Rochester researchers say a benefit of daily prenatal vitamin D in preventing asthma in children up to 3 found in their 2016 study doesn't extend until age 6. They encourage more research, including analyzing whether supplementation should continue in young children.

UK Reveals Plans For ‘Dynamic’ Post-Brexit Regulatory System

At the end of the Brexit transition period, the UK will be charting its own course through the often choppy seas of medicines regulation. While it plans to retain the existing EU rules that have been transposed into domestic legislation, it also wants the freedom to tailor its regulations in areas like clinical trials, advanced therapies and product labeling.

UsernamePublicRestriction

Register

PS047824

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel